SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Breakthrough Company????? Endovasc ENDV

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr David Summers who wrote (34)4/18/1999 1:24:00 PM
From: Mack Carter   of 94
 
Just a Rumor???

Hello,

I just recieved an email that appears related to this company and topic. Having no prior knowledge of the company and finding little on the web can anyone update me? I'd like to know if the information is accurate.

M

Date: Sat, 17 Apr 99 16:53:04 EST
From: stockgenwatch@suri.co.jp
To: newupdate@wilmington.net
Subject: RE: BIOTECH BARGAIN!

Company: Endovasc Ltd., Inc.
Symbol: E N D V
Price: 9/16 ($.56/share)

Whisperstocks indicates persistent
and credible rumours of a $4/share buyout
of ENDV by a major pharamceutical.

The April issue of the British Biotechnology
Journal, Oxford, England states "scientists
at Glaxo Wellcome have proven the efficacy of Endovasc's PGE-1 and
have submitted to management
a multi-million dollar joint venture proposal".

ENDV is recommended as an immediate and "STRONG BUY".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext